Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/12/2026

1. RKLB
2. SPY
3. ACVA
4. CRWV
5. RIOT
6. RPD
7. FERG
8. NVDA
9. HIMS
10. BBIO

Go back to Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
(NYSE: CAMX) Delayed: 35.86 -0.1 (0.28%)
Previous Close $35.96    52 Week High $ 
Open $35.94    52 Week Low $ 
Day High $35.94    P/E N/A 
Day Low $35.86    EPS $ 
Volume 302       

(NYSE: CAMX) Delayed: 35.86 -0.1 (0.28%)
Previous Close $35.96    52 Week High $ 
Open $35.94    52 Week Low $ 
Day High $35.94    P/E N/A 
Day Low $35.86    EPS $ 
Volume 302       

(NYSE: CAMX) Delayed: 35.86 -0.1 (0.28%)
Previous Close $35.96    52 Week High $ 
Open $35.94    52 Week Low $ 
Day High $35.94    P/E N/A 
Day Low $35.86    EPS $ 
Volume 302       

(NYSE: CAMX) Delayed: 35.86 -0.1 (0.28%)
Previous Close $35.96    52 Week High $ 
Open $35.94    52 Week Low $ 
Day High $35.94    P/E N/A 
Day Low $35.86    EPS $ 
Volume 302